Biomarker for diagnosing or predicting reactivity of ovary to fsh and use thereof

A follicle-stimulating hormone-responsive technology, applied in the field of biomarkers and uses thereof for diagnosing or predicting the responsiveness of the ovary to follicle-stimulating hormone, capable of solving problems such as the lack of diagnostic guidelines

Pending Publication Date: 2021-04-09
COLLEGE OF MEDICINE POCHON CHA UNIV IND ACADEMIC COOP FOUND
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, ovarian hyporesponse is diagnosed based on the number of eggs recovered (less than 3 to 6) due to lack of specific diagnostic guidelines (measurement time point, diameter criteria of growing follicles)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarker for diagnosing or predicting reactivity of ovary to fsh and use thereof
  • Biomarker for diagnosing or predicting reactivity of ovary to fsh and use thereof
  • Biomarker for diagnosing or predicting reactivity of ovary to fsh and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Example 1. Confirmation of the effect of FSH treatment on granulosa cell lines

[0050] 1.1. Cell lines used

[0051] In 2001, Dr. Nishi's team in Japan established KGN cells from ovarian granulosa carcinoma (ovarian granulosa carcinoma), which is a human ovarian granulosa cell-like tumor cell line that exhibits a female reproductive hormone secretion state similar to granulosa cells. Since then, KGN cells have been used in studies requiring large numbers of cells, such as characterization of granulosa cells in females and screening of responses to endocrine-disrupting substances. In this specification, before studying various characteristics of female granulosa cells that are difficult to obtain, through this study, a series of studies were conducted to establish a granulosa cell culture system and accumulate in various germ cells used to increase female reproductive capacity Basic data required in the application. The present inventors used human ovarian granulosa c...

Embodiment 2

[0063] Example 2. Derivation of biomarkers for diagnosis of ovarian insufficiency

[0064] To derive biomarkers for the diagnosis of ovarian insufficiency, differentially expressed miRNAs according to FSH responsiveness were confirmed by miRNA microarray. After extracting the total RNA of the cells and removing the 5'-terminal phosphate group with calf intestinal alkaline phosphatase (Calf IntestinalAlkaline Phosphatase; CIP), the Cy3 fluorescent dye was labeled. The labeled RNA was fully reacted with the microarray slide at 56°C for 16 hours, and then washed. The slides were scanned using an Agilent G2565CA Microarray Scanner System, and then the fluorescence intensity was quantified to analyze differences in miRNA expression between groups. Quantitative values ​​were analyzed after normalization using GeneSpring GX 13.1.

[0065] Specifically, when FSH was separately treated in the KGN cell line as a control group and the KGN cell line in which FSHR expression was suppress...

Embodiment 3

[0077] Example 3. Validation of biomarkers

[0078]Whether the expression of CYP19A1 and ESR1 (ER-α) in granulosa cells was reduced by treatment with MiR-4463 was confirmed as follows. In order to confirm whether miR-4463 treatment changes the secretion of estrogen in granulosa cells, western blotting was used to confirm whether the untreated KGN cell line (MOCK), the KGN cell line treated with miR-4463 mimic (miR- 4463 mimetisome) and the expression levels of CYP19A1, ER-α and ER-β proteins in KGN cell lines treated with miR-4463 inhibitor (miR-4463 inhibitor).

[0079] Figure 4 In order to confirm by Western blot in the untreated control KGN cell line (MOCK), the KGN cell line treated with miR-4463 mimic (miR-4463 mimic) and the KGN cell line treated with miR-4463 inhibitor Graph of expression levels of CYP19A1, ER-α and ER-β proteins in (miR-4463 inhibitor).

[0080] Such as Figure 4 As shown, the expression levels of CYP19A1 and ER-α were significantly reduced by miR...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a biomarker for diagnosing or predicting reactivity of an ovary to FSH and a use thereof. According to a composition for diagnosing or predicting reactivity of an ovary to FSH, a kit, and a method using same in accordance with one aspect, the degree of reactivity of the ovary can be easily diagnosed using miRNA present in blood, follicular fluid, granule cells, and cumulus cells, and thus, it is easy to predict or diagnose symptoms or diseases caused by abnormal reactivity of an ovary to FSH.

Description

technical field [0001] The present invention relates to a biomarker for diagnosing or predicting the responsiveness of the ovary to follicle-stimulating hormone (FSH) and its use. Background technique [0002] Despite the recent leaps in assisted reproductive technology, pregnancy success rates after in vitro fertilization and embryo transfer are only around 30% to 40%. These low pregnancy success rates were due to low post-IVF pregnancy success rates in patients with reduced ovarian function who had a poor response to induction of superovulation (ovarian hyporesponse group). That is, the biggest impediment factor in efforts to increase the overall pregnancy rate is recognized as ovarian insufficiency. [0003] In April 2011, the European Society for Human Reproduction and Embryology (ESHRE) proposed two of the following three items as diagnostic criteria: when the maternal age is 40 years or older or has When risk factors for poor response, previous adverse reaction (fewe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883
CPCC12Q1/6883C12Q2600/106C12Q2600/178C12Q2600/158G01N2800/367
Inventor 李暻娥弓美卿李秀娟
Owner COLLEGE OF MEDICINE POCHON CHA UNIV IND ACADEMIC COOP FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap